首页|期刊导航|Hepatobiliary & Pancreatic Diseases International|Nrf2 and Her3 co-expression in cholangiocarcinoma:Possible biological pathways for potential therapeutic approach
Nrf2 and Her3 co-expression in cholangiocarcinoma:Possible biological pathways for potential therapeutic approach
Paola Parente Valentina Angerilli Giuseppe Zamboni Angelo Sparaneo Fabiola Fiordelisi Leonarda Di Candia Matteo Fassan Paolo Graziano
Hepatobiliary & Pancreatic Diseases International2024,Vol.23Issue(3):P.317-321,5.
Hepatobiliary & Pancreatic Diseases International2024,Vol.23Issue(3):P.317-321,5.DOI:10.1016/j.hbpd.2023.02.010
Nrf2 and Her3 co-expression in cholangiocarcinoma:Possible biological pathways for potential therapeutic approach
摘要
关键词
carcinoma/gallbladder/Nrf2分类
医药卫生引用本文复制引用
Paola Parente,Valentina Angerilli,Giuseppe Zamboni,Angelo Sparaneo,Fabiola Fiordelisi,Leonarda Di Candia,Matteo Fassan,Paolo Graziano..Nrf2 and Her3 co-expression in cholangiocarcinoma:Possible biological pathways for potential therapeutic approach[J].Hepatobiliary & Pancreatic Diseases International,2024,23(3):P.317-321,5.基金项目
This study was supported by a grant from the Italian Ministry of Health,Ricerca Corrente Program 2016-2018 to Paola Parente. ()